Maureen Hennessey, PhD, CPCC, CPHQ

Pharma Insights

Bringing Social Determinants of Health to Life to Optimize Health Outcomes in Patients With Chronic Conditions

02/15/2022

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...

Elizabeth Oyekan, PharmD, FCSHP,...

02/15/2022

Journal of Clinical Pathways

Pharma Insights

Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model

09/18/2020

Maureen Hennessey , PhD, CPCC, CPHQ;

Larry Blandford , PharmD;

The Centers for Medicare & Medicaid Services (CMS) announced its third annual evaluation report of the Oncology Care Model (OCM) in July 2020, covering performance periods 1-3 activities and results. In March...

The...

09/18/2020

Journal of Clinical Pathways

Pharma Insights

The Health Care Ecosystem and Social Determinants of Health: Surveys Suggest the Stage Is Set for Novel Collaborations

05/15/2019

Larry Blandford , PharmD;

Maureen Hennessey , PhD, CPCC, CPHQ;

Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...

Dr...

05/15/2019

Journal of Clinical Pathways

Pharma Insights

Value Transformation: Observations on the Second Annual Evaluation Report of the Oncology Care Model

03/13/2019

Maureen Hennessey , PhD, CPCC, CPHQ;

Larry Blandford , PharmD;

Linda Bolland , PharmD, MBA;

The Centers for Medicare & Medicaid Services (CMS) posted its second annual evaluation report of the Oncology Care Model (OCM) in December 2018, covering first performance period and model year results. This...

The...

03/13/2019

Journal of Clinical Pathways